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The haemostatic system comprises 6 main components, i.e. (i) plate ­
lets; (ii) vascular endothelium; (iii) coagulation proteins; (iv) natural 
anticoagulants; (v) the fibrinolytic system; and (vi) natural anti­
fibrinolytic factors.
The haemostatic system is designed to protect against 
exsanguination through generation of thrombi at sites of injury, while 
simultaneously maintaining blood fluidity. This delicate balance 
is highly regulated and achieved through a complex interplay of 
procoagulant and anticoagulant proteins within the vascular system. 
Numerous acquired and congenital conditions may tip the balance 
either way, i.e. towards a prothrombotic or prohaemorrhagic state.
Thromboembolic conditions are the leading cause of mortality, 
estimated to account for 1 in 4 deaths worldwide in 2010. Over time, 
the incidence and mortality rates of these conditions have improved 
in developed countries, but are increasing in developing countries.[1] 
Consequences of thrombosis include ischaemia or infarction (arterial 
thrombi), oedema (venous thrombi) and embolisation. Clinicians in 
southern Africa need to become more cognisant of this devastating 
disease. 
Because of the vastness of the topic, it is spread over 2 parts in CME. 
Part 1 discusses inherited thrombophilia (current issue), and acquired 
forms are discussed in part 2 (forthcoming issue). The content covers 
pathophysiological and diagnostic aspects, and is aimed at enhancing 
insight into the subject – thereby equipping the general practitioner 
to institute appropriate action with regard to investigation, initial 
management and referral. As current management practice is beyond 
the scope of this CME, readers are directed to the South African 
prophylactic and therapeutic guideline in this regard.[2] 
The authors are indeed grateful for the 
opportunity to discuss this important and 
dynamic segment of coagulation disorders.
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